~533 spots leftby Sep 2033

Antibiotics for Pediatric Broken Bones

Recruiting in Palo Alto (17 mi)
SR
Overseen bySivashanmugam Raju, MD
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: St. Louis University
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.

Research Team

SR

Sivashanmugam Raju, MD

Principal Investigator

St. Louis University

Eligibility Criteria

This trial is for children and teens (0-17 years old) with immature bones who have a mild to moderate open fracture that happened within the last day. They must be able to take cephalosporin antibiotics, not need surgery for the fracture, and speak English.

Inclusion Criteria

I have a minor to moderate open fracture that occurred within the last day.
Patients under 18 years of age, as determined by radiologic imaging assessed by an orthopaedic doctor.
I am 17 years old or younger.
See 1 more

Exclusion Criteria

Allergies to cephalosporins
I am 18 years old or older.
You have a severe allergic reaction to penicillin.
See 6 more

Treatment Details

Interventions

  • Cefazolin (Anti-tumor antibiotic)
  • Cephalexin (Anti-tumor antibiotic)
Trial OverviewThe study compares infection rates in young patients with open fractures using different antibiotic treatments: one dose of IV cefazolin, 24 hours of IV cefazolin, or 24 hours of IV cefazolin plus 5 days oral cephalexin.
Participant Groups
3Treatment groups
Active Control
Group I: One dose of IV cefazolinActive Control1 Intervention
Patients in group A will receive one dose of IV cefazolin and will have no further antibiotic administration.
Group II: 24 hours IV cefazolinActive Control1 Intervention
Patients in group B will receive a dose of IV cefazolin every 8 hours for 24 hours (a total of 3 doses).
Group III: 24 hours IV cefazolin plus 5 days oral cephalexinActive Control2 Interventions
Patients in group C will receive a dose of IV cefazolin every 8 hours for 24 hours (a total of 3 doses). Additionally, they will be instructed to take 5 days of oral cephalexin.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Saint Louis UniversitySaint Louis, MO
Loading ...

Who Is Running the Clinical Trial?

St. Louis University

Lead Sponsor

Trials
197
Patients Recruited
41,400+